Fertility-sparing management and obstetric outcomes in a 20-year-old patient with a Sertoli-Leydig cell tumor of the ovary: A case report and review of the literature

Stavrakis,Thomas; Kalogiannidis,Ioannis; Petousis,Stamatios; Tsompanidou,Chrisoula; Delkos,Dimitris; Prapas,Nikolaos; Rousso,David

doi:10.3892/ol.2016.4695

Fertility-sparing management and obstetric outcomes in a 20-year-old patient with a Sertoli-Leydig cell tumor of the ovary: A case report and review of the literature

Authors:
- Thomas Stavrakis
- Ioannis Kalogiannidis
- Stamatios Petousis
- Chrisoula Tsompanidou
- Dimitris Delkos
- Nikolaos Prapas
- David Rousso
View Affiliations

Affiliations: Third Department of Obstetrics and Gynecology, Aristotle University of Thessaloniki, 54642 Thessaloniki, Greece, Department of Pathology, ‘Agios Dimitrios’ General Hospital, 54634 Thessaloniki, Greece
Published online on: June 9, 2016 https://doi.org/10.3892/ol.2016.4695
Pages: 1079-1082

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Sertoli‑Leydig cell tumors (SLCTs) are an uncommon subtype of sex‑cord stromal tumors of the ovary, which most commonly arise in women of reproductive age, creating an issue with regard to the preservation of fertility. The clinical manifestation of SLCTs varies widely, ranging from an asymptomatic clinical profile to extreme virilization. Correct diagnosis of SLCT is crucial and is primarily based on histopathological results. The current study presents the case of a 20‑year‑old woman who underwent unilateral salpingo‑oophorectomy and adjuvant chemotherapy due to the diagnosis of an SLCT of the left ovary. Almost 2 years after the initial surgery, during the follow‑up period, the patient conceived normally. Pregnancy was uneventful and the patient vaginally delivered a healthy infant at 38 weeks of gestation. A total of 1 year after delivery (3 years after the initial diagnosis), follow‑up of the patient did not reveal any disease recurrence. In conclusion, SLCTs may be adequately treated by fertility‑sparing surgery and chemotherapy in young women who wish to preserve their fertility. Natural conception, an uncomplicated pregnancy and a vaginal delivery are possible.

View Figures

View References

1	Young RH and Scully RE: Ovarian Sertoli-Leydig cell tumors. A clinicopathological analysis of 207 cases. Am J Surg Pathol. 9:543–569. 1985. View Article : Google Scholar : PubMed/NCBI
2	Tomlinson MW, Treadwell MC and Deppe G: Platinum based chemotherapy to treat recurrent Sertoli-Leydig cell ovarian carcinoma during pregnancy. Eur J Gynaecol Oncol. 18:44–46. 1997.PubMed/NCBI
3	Sachdeva P, Arora R, Dubey C, Sukhija A, Daga M and Singh DK: Sertoli-Leydig cell tumor: A rare ovarian neoplasm. Case report and review of literature. Gynecol Endocrinol. 24:230–234. 2008. View Article : Google Scholar : PubMed/NCBI
4	Litta P, Saccardi C, Conte L, Codroma A, Angioni S and Mioni R: Sertoli-Leydig cell tumors: Current status of surgical management: Literature review and proposal of treatment. Gynecol Endocrinol. 29:412–417. 2013. View Article : Google Scholar : PubMed/NCBI
5	Young R: Sex cord-stromal, steroid cell, and other ovarian tumors with endocrine, paraendocrine, and paraneoplastic manifestations. Blaustein's Pathology of the Female Genital Tract. Kurman RJ, Hedrick Ellenson L and Ronnett BM: (6th). Springer-Verlag. (New York, NY). 8152011.
6	National Comprehensive Cancer Network (NCCN): NCCN Clinical Practice Guidelines in Oncology: Ovarian Cancer. 2013.https://www.nccn.org/professionals/physician_gls/f_guidelines.aspAccessed. November 24–2014
7	Rio Frio T, Bahubeshi A, Kanellopoulou C, Hamel N, Niedziela M, Sabbaghian N, Pouchet C, Gilbert L, O'Brien PK, Serfas K, et al: DICER1 mutations in familial multinodular goiter with and without ovarian Sertoli-Leydig cell tumors. JAMA. 305:68–77. 2011. View Article : Google Scholar : PubMed/NCBI
8	Slade I, Bacchelli C, Davies H, Murray A, Abbaszadeh F, Hanks S, Barfoot R, Burke A, Chisholm J, Hewitt M, et al: DICER1 syndrome: Clarifying the diagnosis, clinical features and management implications of a pleiotropic tumour predisposition syndrome. J Med Genet. 48:273–278. 2011. View Article : Google Scholar : PubMed/NCBI
9	Meyer R: The pathology of some special ovarian tumors and their relation to sex characteristics. Am J Obstet Gynecol. 22:697–713. 1931. View Article : Google Scholar
10	Gui T, Cao D, Shen K, Yang J, Zhang Y, Yu Q, Wan X, Xiang Y, Xiao Y and Guo L: A clinicopathological analysis of 40 cases of ovarian Sertoli-Leydig cell tumors. Gynecol Oncol. 127:384–389. 2012. View Article : Google Scholar : PubMed/NCBI
11	Novak ER and Long JH: Arrhenoblastoma of the ovary. Am J Obstet Gynecol. 92:1082–1093. 1965. View Article : Google Scholar : PubMed/NCBI
12	Chang PL, Lindheim SR, Lowre C, Ferin M, Gonzalez F, Berglund L, Carmina E, Sauer MV and Lobo RA: Normal ovulatory women with polycystic ovaries have hyperandrogenic pituitary-ovarian responses to gonadotropin-releasing hormone-agonist testing. J Clin Endocrinol Metab. 85:995–1000. 2000. View Article : Google Scholar : PubMed/NCBI
13	Lenhard M, Kuemper C, Ditsch N, Diebold J, Stieber P, Friese K and Burges A: Use of novel serum markers in clinical follow-up of Sertoli-Leydig cell tumours. Clin Chem Lab Med. 45:657–661. 2007. View Article : Google Scholar : PubMed/NCBI
14	Fleckenstein G, Sattler B, Hinney B, Wuttke W, Osmers R and Emons G: Androblastoma of the ovary: Clinical, diagnostic and histopathologic features. Onkologie. 24:286–291. 2001.(In German). PubMed/NCBI
15	Virk R and Lu D: Mucinous adenocarcinoma as heterologous element in intermediately differentiated Sertoli-Leydig cell tumor of the ovary. Pathol Res Pract. 206:489–492. 2010. View Article : Google Scholar : PubMed/NCBI
16	Persechini ML, Motton S, Leguevaque P, Donadille F, Escourrou G, Vierasu B, Hamdi S, Bennet A and Caron P: Virilising ovarian tumour: A case associating a Sertoli-Leydig cell tumour and a Brenner tumour. Gynecol Endocrinol. 27:345–350. 2011. View Article : Google Scholar : PubMed/NCBI
17	Sigismondi C, Gadducci A, Lorusso D, Candiani M, Breda E, Raspagliesi F, Cormio G, Marinaccio M and Mangili G: Ovarian Sertoli-Leydig cell tumors. A retrospective MITO study. Gynecol Oncol. 125:673–676. 2012. View Article : Google Scholar : PubMed/NCBI
18	Brown J, Sood AK, Deavers MT, Milojevic L and Gershenson DM: Patterns of metastasis in sex cord-stromal tumors of the ovary: Can routine staging lymphadenectomy be omitted? Gynecol Oncol. 113:86–90. 2009. View Article : Google Scholar : PubMed/NCBI